Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

Last updated: April 18, 2024
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sjogren's Syndrome

Eye Disorders/infections

Allergy

Treatment

Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry

Clinical Study ID

NCT04198740
CE19.212
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with healthy corneas or suffering from one of these pathologies: Dry eye syndrome; Infectious keratitis and/or conjunctivitis; Mucous membrane pemphigoid;Allergic conjunctivitis.

Exclusion

Exclusion Criteria:

  • Patients younger than 18 years old;
  • Patients incapable of giving informed consent.

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry
Phase:
Study Start date:
February 01, 2020
Estimated Completion Date:
January 31, 2035

Study Description

This is an exploratory study. The investigators aim to:

  • Test and perfect a tear sample analysis technique by mass spectrometry with samples collected by Schirmer strips;

  • Obtain the lacrimal fingerprint for various pathologies of the ocular surface, notably different forms of dry eye syndrome, infectious keratitis/conjunctivitis, mucous membrane pemphigoid and allergic conjunctivitis, and establish a normative base for each of them.

During regular clinics at the cornea service of the ophthalmology department of the CHUM (Centre Hospitalier de l'Université de Montréal), the investigators aim to recruit a few hundred patients with various pathologies of the ocular surface, notably different forms of dry eye syndrome, infectious keratitis/conjunctivitis, mucous membrane pemphigoid and allergic conjunctivitis, and collect a sample of their tears via Schirmer strip. A case report form will be completed for each patient, noting known ocular diagnoses and active topical ophthalmic medication. Schirmer strips will be sent in sterile tubes to UQAM (Université du Québec à Montréal)'s department of chemistry for analysis by mass spectrometry.

Connect with a study center

  • Centre Hospitalier de l'Université de Montréal (CHUM)

    Montreal, Quebec H2X 3E4
    Canada

    Active - Recruiting

  • Université du Québec à Montréal (UQAM) - Department of Chemistry

    Montreal, Quebec H2X 2J6
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.